Objective To perform a systematic review and meta-analysis of reported estimates of adverse pregnancy outcomes among untreated syphilitic women and nonsyphilitic women.
Introduction
In 2008, the World Health Organization (WHO) estimated that 1.86 million cases of syphilis occur globally among pregnant women each year and that a large proportion of them are untreated or inadequately treated. Up to one third of the women attending antenatal care (ANC) clinics are not tested for syphilis. 1 If syphilis is left untreated during pregnancy, it can lead to fetal loss or stillbirth or, in a liveborn infant, neonatal death, prematurity, low birth weight or congenital syphilis. Programmes that include syphilis testing coupled with appropriate, prompt penicillin treatment for pregnant women who test positive for Treponema pallidum infection have been shown to be efficacious in reducing adverse pregnancy outcomes. [2] [3] [4] In addition, these interventions have been estimated to be highly cost-effective, even in settings where the burden of syphilis among pregnant women is moderate or low. [5] [6] [7] [8] Existing barriers to scaling up these programmes can only be overcome through active involvement from policy-makers. Evidence-based estimates of the burden of congenital syphilis at the global, national and subnational levels help make the case for allocating resources to these effective programmes, increasing access to interventions and making progress towards elimination. Calculating the burden relies on precise estimates of the local prevalence of syphilis and adverse pregnancy outcomes among untreated syphilitic women.
Previous estimates of adverse pregnancy outcomes in syphilitic women have been based on point estimates from single studies. To improve the quality of these estimates in the context of WHO's global initiative for the elimination of congenital syphilis, 9, 10 we performed a systematic review and meta-analysis of reported estimates of adverse pregnancy outcomes among untreated syphilitic and non-syphilitic women.
Methods
We performed a systematic review and meta-analysis that accorded with MOOSE guidelines 11 and PRISMA requirements.
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Search strategy and inclusion criteria
We systematically searched the published literature without date or language restrictions to identify studies assessing pregnancy outcomes in the presence of maternal syphilis. We used combinations of the following terms to search PubMed, EMBASE and Cochrane Libraries: Because our goal was to estimate the range of possible birth outcomes associated with untreated syphilis during pregnancy, our population of interest was pregnant women who had untreated syphilis. We included studies that described pregnancy outcomes among women presumed to have syphilis (i.e. women who were seroreactive for T. pallidum infection, irrespective of the test used), as well as uninfected (i.e. control) women. We focused on fetal, neonatal and infant outcomes because maternal outcomes of syphilis would not be expected for several years after disease onset and were unlikely to have been reported in the same studies. We included studies of at least 30 patients that described the sampling strategy used to recruit patients from the community, hospitals or ANC clinics. We excluded studies describing partially treated populations, unless adverse pregnancy outcomes were reported specifically among women who lacked syphilis testing or treatment (i.e. at least 2.4 million U of intramuscular penicillin). We considered a broad range of study designs, including clinical trials, observational studies, programme reviews and case series. We assessed potential studies to ensure that there was no duplication of case series.
The data extracted included study characteristics such as study year, geographical location, diagnostic test used, sample size for cases and controls, design, length of follow-up, type of outcome and frequency estimates for T. pallidum-associated seroreactivity in the study population or a comparable population from the same setting and period. We performed group-specific analyses for all adverse outcomes and for specific adverse outcomes to explore the sources of heterogeneity. We defined three groups of studies. Group 1 included studies calculating the frequency of an adverse pregnancy outcome involving women whose reproductive history was recorded before the existence of penicillin treatment. Group 2 comprised studies in which the frequency of an adverse pregnancy outcome was calculated for women attending an ANC clinic that offered no treatment or testing for syphilis. Group 3 comprised studies that examined the frequency of an adverse pregnancy outcome involving women attending an ANC clinic in which recruitment in the study was done at the time of delivery (and syphilis treatment was only available at that time). All data were prepared and analysed using Stata/SE version 11.0 (StataCorp. LP, College Station, United States of America).
Results
Overall, 3258 citations were retrieved. Six articles 6, [16] [17] [18] [19] [20] were considered eligible for the study included a "control" arm assessing adverse pregnancy outcomes among non-syphilitic women. Of these studies, Harman's investigation of family histories of infants with blindness predated the availability of syphilis treatment and was classified as a group 1 study. 16 Harman tabulated all pregnancy outcomes and child deaths from birth through the first year of life over the reproductive histories (as many as 18 pregnancies) of 150 "syphilitic" mothers and were ANC evaluation studies conducted in the context of poorly implemented syphilis screening/treatment programmes; both investigations were considered to be group 3 studies. 6, 20 All studies reported on stillbirth or fetal loss. Only three studies reported on neonatal death. [17] [18] [19] Five studies reported on clinical evidence of congenital syphilis in children 6, [16] [17] [18] 20 and four studies reported on prematurity or low birth weight. 6, 17, 18, 20 Only
McDermott et al. looked at infant death (i.e. deaths among subjects aged 29 days to one year). 19 All adverse pregnancy outcomes All studies consistently reported a higher proportion of adverse pregnancy outcomes among untreated syphilitic women (range: 53.4-81.8%) than among non-syphilitic women (range: 10.2-20.8%). Fig. 2 shows the study-specific and summary estimates for all adverse pregnancy outcomes. Fig. 3 and Fig. 4 show study-specific estimates for select adverse pregnancy outcomes and their summary statistics in syphilitic and non-syphilitic women, respectively. However, these data could not be subclassified into neonatal and infant deaths because
Selected adverse pregnancy outcomes
Harman reported deaths during the period from birth to one year of age.
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Pooled estimates and heterogeneity
Meta-analysis of the estimates of all adverse outcomes across the six studies revealed substantial heterogeneity for both syphilitic (I 2 = 91.8%; P < 0.001) and non-syphilitic women (I 2 = 95.9%; P < .001; Fig. 2 ). A group-specific analysis of all adverse outcomes revealed a marked difference between estimates for syphilitic women, with the highest summary statistic observed for group 2 and the lowest observed for group 3 (Appendix A, available at: www.who.int/reproductivehealth/publications/rtis/syphilis_in_pregnancy/en/m).
Heterogeneity was acceptable only for group 3 (56.4% [95% CI: 50.8-61.9]; I 2 = 0.0%; P = 0.547). Among non-syphilitic women, the summary statistic was highest for group 1 and lowest for group 3 (Appendix A). Again, heterogeneity was acceptable only for group 3 (10.3% [95% CI: 9.2-1.5]; I 2 = 0.0%; P = 0.658).
We also analysed summary estimates of selected adverse pregnancy outcomes by study group in syphilitic and non-syphilitic women (Appendix B and Appendix C, both available at: www.who.int/reproductivehealth/publications/rtis/syphilis_in_pregnancy/en/m).
In syphilitic pregnant women, the summary statistic for stillbirth and fetal loss was highest for group 2 and lowest for group 1. Heterogeneity was acceptable only for group 3 (22.5%
[95% CI: 18.1-27.5]; I 2 = 0.0%; P = .609). The summary statistic for clinical evidence of syphilis was highest for group 2 and lowest for group 3; heterogeneity was acceptable for In non-syphilitic women, the summary statistic for stillbirth and fetal loss was highest for group 1 and comparably low for groups 2 and 3, but heterogeneity was unacceptable for the latter groups (Appendix C). The frequency of prematurity or low birth weight was comparable for groups B and C but heterogeneity was acceptable only for group 3 (7.6%
[95% CI: 4.8-11.7]; I 2 = 68.6%; P = 0.074).
Discussion
In this article, we quantified the proportion of all adverse pregnancy outcomes and specific adverse pregnancy outcomes among untreated women with syphilis and women without syphilis using data from six articles that met eligibility criteria for inclusion in our systematic review and meta-analysis. On average, pooled estimates of fetal loss or stillbirth, neonatal death and prematurity or low birth weight showed significantly higher rates among the offspring of syphilitic women than among the offspring of non-syphilitic women. The absolute differences were 21% for fetal loss or stillbirth, 9% for neonatal death and 6% for prematurity or low birth weight. Signs and symptoms of syphilis were found in 15% of the infants born to untreated women with syphilis. The frequency of any adverse pregnancy outcomes was 52% higher among women with syphilis than among women without syphilis. 25 reported that 39% resulted in perinatal death (although the latter outcome was not defined, it probably included neonatal deaths, stillbirths and fetal losses). Rutgers et al. 24 reported that 27% of infants were "admitted" because they were born before term (2.2%), had a low birth weight (13.5%) or presented with symptoms of congenital syphilis (11.3%).
Only one study evaluated in this report estimated death during the first year of life. It showed that infants delivered by untreated syphilitic mothers had 10% more deaths than those delivered by non-syphilitic mothers. This suggests that a considerable mortality burden is currently overlooked because of short follow-up periods in most cohort studies.
Early investigations evaluating syphilis testing and treatment preceded the use of experimental study designs; later studies have been limited by moral restrictions on the use of Publication: Bulletin of the World Health Organization; Type: Systematic reviews Article ID: BLT.12.107623 randomized controlled designs that withhold an effective intervention from a control group.
Therefore, all studies included in our analysis had an observational design. Nevertheless, one strength of this review is that each study included a comparison group to assess adverse pregnancy outcomes among non-syphilitic mothers. This gave us the opportunity to estimate the excess adverse outcomes in the presence of maternal syphilis and give a broad idea of the risk of some of the adverse pregnancy outcomes in women with untreated syphilis.
Owing to the inherent differences between experimental and observational study designs and to biases commonly seen in observational data, 11 appropriate caution should be taken in interpreting our results. We relied on the outcome definitions used in the original papers, many of which were published before a consensus definition was available. There were also unacceptable heterogeneity in estimates across studies, variations in diagnostic tests across settings and periods, and a lack of control for potential confounders. Several potential sources of bias are present as well. Reporting bias is possible because infants born to mothers known to be syphilitic are more likely than infants born to mothers not known to be syphilitic to be diagnosed with congenital syphilis. Group 2 studies included only asymptomatic women and therefore may have underestimated adverse pregnancy outcomes in women with untreated primary or secondary syphilis, both of which make transmission to offspring more likely and are associated with a fatality rate of nearly 100% (as noted among seven cases included in the Wammock cohort). Primary and secondary syphilis during pregnancy are not estimated to be common, so this potential bias is unlikely to change the magnitude of the findings. Another limitation associated with group 2 is that, although each study followed infants for at least a short period, the length of follow-up varied. Therefore, the burden of congenital syphilis might have been underestimated because congenital syphilis may have been missed in some infants. The lack of a search for grey literature sources could have introduced a reporting bias, but because of the nature of the research assessed we expect this to be minimal.
In the group 1 study, which assessed the lifetime reproductive histories of women infected with T. pallidum before the availability of anti-syphilis treatment, the timing of infection was not reported. This study probably underestimated the proportion of adverse pregnancy outcomes: some pregnancies included in the study may have occurred before women were infected and others may have occurred years after exposure, when syphilis was inactive and less likely to be transmitted to the fetus. Indeed, the risk of adverse pregnancy given the large number of fetal losses in group 2 studies. Second, because penicillin is a highly effective intervention, treating neonates born to seroreactive mothers at birth probably prevented clinical infection or further progression of disease in the infants of infected mothers whose infections were not identified earlier. 2 This bias was important since congenital syphilis in live born infants represented a small fraction of pregnancy outcomes in group 3 studies, compared with group 1 and 2 studies. Third, women in group 3 who partially or fully completed a regimen of syphilis treatment during pregnancy might not have had this information reflected on their maternity card. This would have resulted in the misclassification of some women with syphilis as untreated. Finally, because group 3 studies did not follow up study subjects after delivery, neonatal deaths, infant deaths and clinical manifestations that occurred after this period would have been missed.
Our study suggests that, unless testing and treatment of syphilis in pregnancy are universally available, over half of syphilitic pregnancies will result in an adverse outcome.
This is a preventable burden on mothers, families and health systems that highlights the need to prioritize global efforts to eliminate the mother-to-child transmission of syphilis. This paper also reminds policy-makers charged with resource allocation that the elimination of congenital syphilis is a public health priority that will enable immediate progress towards Millennium Development Goal 4: reducing the mortality rate among children younger than 5 years by two thirds. 
Kahn test
This study assessed best practices in providing penicillin to pregnant women to prevent congenital syphilis and was done shortly after penicillin became available. Background data on APOs among untreated women who were seroreactive for T. pallidum infection were reported; uninfected women (historical controls) were used as a comparison group. Of 61 cases of early syphilis, 7 were "symptomatic" (which seems to correspond to primary or secondary infection) and resulted in no "normal living infants" (i.e. 2 stillbirths, 1 neonatal death and 4 infants with congenital syphilis). The remaining 54 cases had "early latent" syphilis (defined as "symptomless" seropositivity for T. pallidum infection of < 4 years' duration): these cases are combined with the 61 early cases in the meta-analysis. There were 14 cases with "late latent syphilis" (defined as symptomless infection of This study described pregnancy outcomes among asymptomatic women with and without syphilis at two public hospitals in Philadelphia, United States of America. Asymptomatic women consisted of subjects who were seroreactive for T. pallidum infection and either untreated, treated with arsenicals or treated with various doses of penicillin. Subjects were followed for at least 60 days after delivery (77% were followed for 6 months). On the basis of clinical history, 220 of 302 women had "early" syphilis (defined as untreated syphilis of < 4 years' duration) and 82 had "late" syphilis (defined as untreated syphilis of > 4 years' duration). APOs were stillbirths for 10, neonatal deaths for 7, prematurity for 2 and congenital syphilis for 2; 61 women had "normal full-term infants". Hira "Relatively representative" pregnant women in urban and rural settings were recruited at delivery and tested for syphilis. Unscreened women, defined as those who had no ANC care or who did not have records of syphilis screening on their ANC card (17%), were invited to participate in screening at delivery (participation rate, 51%). Two consecutive women with an unreactive T. pallidum serologic test were selected as controls for each case, defined as a woman with high-or low-titre T. pallidum infection. The study assessed APOs in 73 women with high-titre T. pallidum infection (defined as an RPR titre of ≥ 1:8 and a positive result of a confirmatory test), 27 women with low-titre T. pallidum infection (defined as an RPR titre of < 1:8 and a positive result of a confirmatory test), 9 women with past or currently treated syphilis (defined as a negative result of an RPR test and a positive result of a treponemal test) and 233 women who were seronegative for T. pallidum infection. As soon as possible after delivery, treatment was administered to women with high-or low-titre T. pallidum infection and their infants. Study authors defined "stillbirth" (i.e. dead fetus > 22 weeks' gestation), "intrauterine fetal death" (i.e. fetal death ≤ 22 weeks' gestation) and "low birth weight" (i.e, < 2500 g). There were no intrauterine fetal deaths. Among unscreened women, the population attributable fraction of APOs due to high-titre T. pallidum infection was 51% for Additional records identified through other sources (references in seminal papers, review articles, medical textbooks, expert opinion)
Records screened n = 3258
Records excluded, n = 3156
Full-text articles assessed for eligibility n = 102
Full text articles excluded, n = 96 Treatment of syphilitic women, n = 74 Special populations, n = 9 Limited reporting of birth outcomes, n = 7 Number of patients < 30, n = 4 Duplicate reports, n = 2
Studies included in the review n = 6 
